» Articles » PMID: 39584485

Vitamin D Supplementation Can Improve the 28-day Mortality Rate in Patients with Sepsis-associated Acute Kidney Injury

Overview
Journal Ren Fail
Publisher Informa Healthcare
Date 2024 Nov 25
PMID 39584485
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Vitamin D levels are generally lower in septic patients and are associated with poor prognosis. Observational studies suggest improved renal recovery in acute kidney injury (AKI) patients with increased vitamin D levels. Still, large RCTs did not show significant clinical benefits, possibly due to the limited number of sepsis or AKI patients included. This study aimed to examine the impact of vitamin D supplementation on 28-day all-cause mortality in patients with sepsis-associated acute kidney injury (S-AKI).

Methods: A retrospective cohort study was conducted using data from the MIMIC-IV (v2.0) database, which included 18,713 ICU patients with S-AKI. Propensity score matching (PSM) was used to adjust for confounding factors, and multivariate Cox regression was employed to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Patient survival and clinical characteristics will be assessed utilizing Kaplan-Meier curves, with comparisons conducted using the log-rank test.

Results: Kaplan-Meier survival analysis revealed significant differences in survival between the groups. Multivariate Cox regression indicated a reduced risk of 28-day mortality associated with vitamin D supplementation (HR: 0.73, 95% CI: 0.67-0.80,  < 0.001). The results after PSM were consistent with those of the original cohort. Similar results were observed for in-hospital mortality and 90-day mortality. The Restricted Cubic Spline curve (RCS) indicated an increasing trend in the therapeutic effect of vitamin D with increasing SOFA score.

Conclusions: Vitamin D supplementation is associated with decreased all-cause mortality in patients with S-AKI, and those with more severe conditions may benefit even more.

References
1.
Amrein K, Schnedl C, Holl A, Riedl R, Christopher K, Pachler C . Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. JAMA. 2014; 312(15):1520-30. DOI: 10.1001/jama.2014.13204. View

2.
Chang Y, Chou Y, Kan W, Shiao C . Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay. Int J Mol Sci. 2022; 23(16). PMC: 9408949. DOI: 10.3390/ijms23169159. View

3.
Yang B, Zhu Y, Zheng X, Li T, Niu K, Wang Z . Vitamin D Supplementation during Intensive Care Unit Stay Is Associated with Improved Outcomes in Critically Ill Patients with Sepsis: A Cohort Study. Nutrients. 2023; 15(13). PMC: 10346786. DOI: 10.3390/nu15132924. View

4.
Hwang H, Yang K, Park K, Choi H, Kim S, Hong S . Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2. Nephrol Dial Transplant. 2012; 28(5):1156-66. DOI: 10.1093/ndt/gfs540. View

5.
Cui A, Xiao P, Ma Y, Fan Z, Zhou F, Zheng J . Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001-2018. Front Nutr. 2022; 9:965376. PMC: 9573946. DOI: 10.3389/fnut.2022.965376. View